Dermata Therapeutics Files 8-K on Security Holder Vote
Ticker: DRMAW · Form: 8-K · Filed: Jul 16, 2025 · CIK: 1853816
| Field | Detail |
|---|---|
| Company | Dermata Therapeutics, Inc. (DRMAW) |
| Form Type | 8-K |
| Filed Date | Jul 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: DRMA
TL;DR
DRMA filed an 8-K for a security holder vote on 7/15/25.
AI Summary
On July 15, 2025, Dermata Therapeutics, Inc. filed an 8-K report indicating that it submitted matters to a vote of its security holders. The filing does not specify the nature of the matters voted upon or the outcome of the vote.
Why It Matters
This filing signals that Dermata Therapeutics held a vote of its security holders, which could pertain to significant corporate actions or governance changes.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose any new financial information or significant operational changes.
Key Players & Entities
- Dermata Therapeutics, Inc. (company) — Registrant
- July 15, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-40739 (commission_file_number) — SEC File Number
- 3525 Del Mar Heights Rd., #322 San Diego, CA 92130 (address) — Principal executive offices
- (858) 800-2543 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of Dermata Therapeutics' security holders?
The filing does not specify the exact matters that were submitted to a vote of security holders.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 15, 2025.
What is Dermata Therapeutics, Inc.'s state of incorporation?
Dermata Therapeutics, Inc. is incorporated in Delaware.
What is the SEC file number for Dermata Therapeutics, Inc.?
The SEC file number for Dermata Therapeutics, Inc. is 001-40739.
Where are Dermata Therapeutics, Inc.'s principal executive offices located?
Dermata Therapeutics, Inc.'s principal executive offices are located at 3525 Del Mar Heights Rd., #322 San Diego, CA 92130.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 16, 2025 regarding Dermata Therapeutics, Inc. (DRMAW).